Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™

Strongbridge Biopharma® has acquired the U.S. and Canadian rights to MACRILENTM (macimorelin) from Aeterna Zentaris Inc. 

Acromegaly Awareness Day

CPPN Creates Inagrual Acromegaly Awareness Day

Acromegaly is a rare disease in adults which is difficult to diagnose due to its slow progression and varied symptoms. Currently, there are at least 2,000 Canadians affected by acromegaly with still more undiagnosed. 

Pituitary on the internet